ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2010

Jan 3, 2010

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR SIMON THOMAS O’LOUGHLIN
Date of last notice	19 JUNE 2007

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	29 DECEMBER 2009

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	38,571 ORDINARY SHARES HELD BYSIMONO’LOUGHLIN<NICHOLASO’LOUGHLIN A/C>328,571 ORDINARY SHARES HELD BYSIMON THOMAS O’LOUGHLIN150,000 OPTIONS EXERCISABLE AT $0.30EACH EXPIRING 15 NOVEMBER 2010300,000 OPTIONS EXERCISABLE AT $0.20EACH, VESTING ON 25 AUGUST 2007AND EXPIRING 1 JUNE 2012 HELD BYSIMON O’LOUGHLIN500,000 OPTIONS EXERCISABLE AT $0.30EACH, VESTING ON 25 AUGUST 2007AND EXPIRING 1 JUNE 2012 HELD BYSIMON O’LOUGHLIN
Class	ORDINARY SHARES
Number acquired	20,000
Number disposed	NIL
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$0.25 PER SHARE
No. of securities held after change	38,571 ORDINARY SHARES HELD BYSIMONO’LOUGHLIN<NICHOLASO’LOUGHLIN A/C>28,571 ORDINARY SHARES HELD BYSIMON THOMAS O’LOUGHLIN320,000 ORDINARY SHARES HELD BYSIMONANDLUCILLEO’LOUGHLIN<O’LOUGHLIN FAMILY SUPER A/C>150,000 OPTIONS EXERCISABLE AT $0.30EACH EXPIRING 15 NOVEMBER 2010300,000 OPTIONS EXERCISABLE AT $0.20EACH, VESTING ON 25 AUGUST 2007AND EXPIRING 1 JUNE 2012 HELD BYSIMON O’LOUGHLIN500,000 OPTIONS EXERCISABLE AT $0.30EACH, VESTING ON 25 AUGUST 2007AND EXPIRING 1 JUNE 2012 HELD BYSIMON O’LOUGHLIN
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	PARTICIPATION IN SHARE PURCHASEPLAN

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

					Appendix 3YChange of Director’s Interest Notice	Appendix 3YChange of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In thdisclosed iDil		e case of a company, interests wn this part.	hich come within paragraph (i		i) of the definition of “notifiable interest of a director” should be
	Dil	f		N/A
	eta	o contract
	Nature	of interest
	Name	of registered holder
	(if issued securities)
	Date of chane
	g
	N d l f iti		t hih
	o. an cass o secureinterest related prior to chNote: Details are only required for a co		s o wcangentract in relation
	to which the interest has changed
	Interest acquired
	Interest disposed
	Value/ConsiderationNt If nidrtin i nnh r		id dtil nd
	oe: coseao s o-cas, pan estimated valuation		ve eas a
	Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002